Table 1 Demographic characteristics among patients who completed both D14 and D28+ surveys vs only D28+ survey
|  | Day 14 and Day 28+ (N = 199) | Day 28+ only (N = 212) | Total (N = 411) |
|---|---|---|---|
Sex assigned at birth | |||
Female | 102 (51.3%) | 117 (55.2%) | 219 (53.3%) |
Male | 97 (48.7%) | 95 (44.8%) | 192 (46.7%) |
Age (years) | |||
Mean (SD) | 49.1 (15.9) | 50.8 (15.5) | 50.0 (15.7) |
Median [Min, Max] | 49.0 [16.0, 88.0] | 51.0 [18.0, 92.0] | 50.0 [16.0, 92.0] |
Age group | |||
 < 18 | 2 (1.0%) | 0 (0%) | 2 (0.5%) |
18–29 | 20 (10.1%) | 19 (9.0%) | 39 (9.5%) |
30–39 | 38 (19.1%) | 30 (14.2%) | 68 (16.5%) |
40–49 | 41 (20.6%) | 43 (20.3%) | 84 (20.4%) |
50–59 | 48 (24.1%) | 62 (29.2%) | 110 (26.8%) |
60 +  | 50 (25.1%) | 58 (27.4%) | 108 (26.3%) |
Race | |||
Non-White | 15 (7.5%) | 24 (11.3%) | 39 (9.5%) |
White | 117 (58.8%) | 132 (62.3%) | 249 (60.6%) |
Unknown | 67 (33.7%) | 56 (26.4%) | 123 (29.9%) |
Ethnicity | |||
Latino/Hispanic | 93 (46.7%) | 138 (65.1%) | 231 (56.2%) |
Non-Latino/Hispanic | 36 (18.1%) | 30 (14.2%) | 66 (16.1%) |
Unknown | 70 (35.2%) | 44 (20.8%) | 114 (27.7%) |
San Diego Region | |||
Central | 75 (37.7%) | 90 (42.5%) | 165 (40.1%) |
East | 24 (12.1%) | 33 (15.6%) | 57 (13.9%) |
North Central | 28 (14.1%) | 14 (6.6%) | 42 (10.2%) |
North Coastal | 1 (0.5%) | 2 (0.9%) | 3 (0.7%) |
North Inland | 7 (3.5%) | 4 (1.9%) | 11 (2.7%) |
Outside County | 3 (1.5%) | 1 (0.5%) | 4 (1.0%) |
South | 59 (29.6%) | 66 (31.1%) | 125 (30.4%) |
Unknown | 2 (1.0%) | 2 (0.9%) | 4 (1.0%) |
FHCSD patient status | |||
FHCSD | 51 (25.6%) | 128 (60.4%) | 179 (43.6%) |
Non-FHCSD | 148 (74.4%) | 84 (39.6%) | 232 (56.4%) |
Primary care provider | |||
FHCSD | 51 (25.6%) | 128 (60.4%) | 179 (43.6%) |
Kaiser Permanente | 49 (24.6%) | 17 (8.0%) | 66 (16.1%) |
Other | 73 (36.7%) | 41 (19.3%) | 114 (27.7%) |
San Ysidro Health | 3 (1.5%) | 3 (1.4%) | 6 (1.5%) |
Scripps | 8 (4.0%) | 12 (5.7%) | 20 (4.9%) |
Sharp | 9 (4.5%) | 10 (4.7%) | 19 (4.6%) |
UCSD | 1 (0.5%) | 1 (0.5%) | 2 (0.5%) |
VA | 5 (2.5%) | 0 (0%) | 5 (1.2%) |
Vaccination status pre-infusion | |||
Fully vaccinated | 98 (49.2%) | 43 (20.3%) | 141 (34.3%) |
Partially vaccinated | 1 (0.5%) | 8 (3.8%) | 9 (2.2%) |
Unvaccinated/unknown | 100 (50.3%) | 161 (75.9%) | 261 (63.5%) |
Language | |||
English | 114 (57.3%) | 98 (46.2%) | 212 (51.6%) |
Spanish | 72 (36.2%) | 103 (48.6%) | 175 (42.6%) |
Unknown | 13 (6.5%) | 8 (3.8%) | 21 (5.1%) |
Other | 0 (0%) | 3 (1.4%) | 3 (0.7%) |
|  | Day 14 and Day 28+ (N = 72) | Day 28+ only (N = 112) | Total (N = 184) |
|---|---|---|---|
Chronic comorbiditiesa | |||
Essential hypertension | 34 (47.2%) | 52 (46.4%) | 86 (46.7%) |
Diabetesb | 21 (29.2%) | 34 (30.4%) | 55 (29.9%) |
Depressive disorders | 9 (12.5%) | 27 (24.1%) | 36 (19.6%) |
Asthma | 9 (12.5%) | 18 (16.1%) | 27 (14.7%) |
Obesity | 11 (15.3%) | 12 (10.7%) | 23 (12.5%) |